Filtros de búsqueda

Lista de obras de

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort study.

artículo científico publicado en 2018

Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer

artículo científico publicado en 2019

Attenuation of equine influenza viruses through truncations of the NS1 protein

artículo científico publicado en 2005

Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine

artículo científico publicado en 2020

Computed Tomography-Derived Radiomic Metrics Can Identify Responders to Immunotherapy in Ovarian Cancer

scientific article published on 15 August 2019

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

scientific article published on 01 March 2020

Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses

artículo científico publicado en 2009

Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity

artículo científico publicado en 2022

Genetically Engineered Oncolytic Newcastle Disease Virus Effectively Induces Sustained Remission of Malignant Pleural Mesothelioma

artículo científico publicado el 21 de septiembre de 2010

Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.

artículo científico publicado en 2017

Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1.

artículo científico publicado en 2005

Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells

artículo científico publicado en 2017

Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity

artículo científico publicado en 2017

Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: a Phase I Study

scientific article published on 25 June 2020

Novel therapeutics: response and resistance in ovarian cancer

scientific article published on 01 August 2019

Ovarian cancer mutational processes drive site-specific immune evasion

artículo científico publicado en 2022

Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer

scientific article published on 01 October 2020

Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients

artículo científico publicado en 2020

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial

artículo científico publicado en 2020

Sequence analysis and receptor specificity of the hemagglutinin of a recent influenza H2N2 virus isolated from chicken in North America

artículo científico publicado en 2006

The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease

artículo científico publicado en 2011

Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy

scientific article published on 01 June 2020